Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

By Comi Giancarlo   Hartung Hans-Peter   Kurukulasuriya Nuwan C   Greenberg Steven J   Scaramozza Matthew  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite

Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: Analysis of Economic Data from the CLARITY Study

By Ali Shehzad  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 15-27

Adis International

Access to resources Recommend Favorite

Emerging oral drugs for relapsing–remitting multiple sclerosis

By Gasperini Claudio   Ruggieri Serena  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 697-712

Informa Healthcare

Access to resources Recommend Favorite

Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosis

By Thööne Jan   Gold Ralf  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 3, 2011-03 ,pp. : 365-370

Informa Healthcare

Access to resources Recommend Favorite

Fingolimod: A Review of its Use in the Management of Relapsing-Remitting Multiple Sclerosis

By Scott Lesley J.  

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 673-698

Adis International

Access to resources Recommend Favorite